The primary treatment approach for Fibrodysplasia Ossificans Progressiva (FOP) focuses on symptom management and flare-up prevention. Since there is no permanent cure for this rare condition, treatment focuses on avoiding trauma, early identification of flare‑ups, and using corticosteroids for short-term flare management. Medication costs vary significantly by brand and dosage. Prednisone may cost between ₹10 and ₹900 per strip/box, while COX‑2 inhibitors such as Etoricoxib typically cost ₹150 – ₹200 per strip.
These are some of the common medications to treat Fibrodysplasia Ossificans Progressiva:
Short courses of corticosteroids (e.g., prednisone 1–2 mg/kg/day for 4 days) may be used for major flare-ups. The average cost of these medicines in India may range from ₹10 and ₹900
NSAIDs or COX-2 inhibitors may be used to manage symptoms during or after flare-ups at physician discretion.In India, NSAID and COX‑2 inhibitor prices vary widely; Etoricoxib typically costs ₹150–₹200 per strip in India.
Prednisone is the preferred medication at flare onset; NSAIDs or COX-2 inhibitors may help with symptoms. Other agents like mast- cell stabilizers or bisphosphonates lack strong evidence and are not standard flare-up treatments.
Surgical removal of heterotopic bone is strongly discouraged because it triggers new bone formation. Some of the most common procedures for excess bone removal in severe cases (only in life‑threatening emergencies) of FOP include curettage and osteotomy and must involve FOP specialists. Curettage is not recommended for FOP-related bone, as any invasive procedure risks inducing further heterotopic ossification. In India, these procedures typically cost between ₹80,000 and ₹2,50,000.
Avoiding trauma is crucial for preventing the formation of new bone in the affected region. This includes avoiding intramuscular injections, dental procedures that can cause jaw trauma, and preventing illnesses like the flu.
Doctors generally do not recommend surgery for treating FOP condition, as it can worsen the condition, leading to new bone formation at the surgical site. However, in serious life-threatening situations, surgical planning with an FOP specialist may be considered.
FOP typically begins in childhood, with the first symptoms often appearing before the age of 10. A hallmark of FOP is the presence of malformed great toes at birth, which can be a key diagnostic indicator.
Doctors generally diagnose FOP through a combination of clinical evaluation, imaging and genetic testing. A physical examination, including checking for malformed great toes, is crucial. Imaging helps visualise heterotopic ossification and pre-osseous lesions. Additionally, testing for the ACVR1 gene mutation confirms the diagnosis.
No, Fibrodysplasia Ossificans Progressiva is not common, as it is a rare genetic disorder. Earlier estimates suggested a prevalence of about 1 in 2 million, but recent studies indicate it may be closer to 1 in 1 million.This condition arises from a complex genetic mutation, which is why it is a subject of ongoing research to understand its mechanisms and develop potential treatments.
Only gentle, non‑traumatic activities (such as breathing or hydrotherapy exercises) are recommended. Stretching or forceful physiotherapy is discouraged because it can trigger new bone formation. Individuals with FOP and their families need to have access to emotional and mental health support.